Stromelysin-1
Also known as: MMP3, STMY1
Function
Metalloproteinase with a rather broad substrate specificity that can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates different molecules including growth factors, plasminogen or other matrix metalloproteinases such as MMP9. Once released into the extracellular matrix (ECM), the inactive pro-enzyme is activated by the plasmin cascade signaling pathway. Also acts intracellularly. For example, in dopaminergic neurons, gets activated by the serine protease HTRA2 upon stress and plays a pivotal role in DA neuronal degeneration by mediating microglial activation and alpha-synuclein/SNCA cleavage. In addition, plays a role in immune response and possesses antiviral activity against various viruses such as vesicular stomatitis virus, influenza A virus (H1N1) and human herpes virus 1. Mechanistically, translocates from the cytoplasm into the cell nucleus upon virus infection to influence NF-kappa-B activities.
Classification
- Family (Pfam)
- PF00045 Hemopexin, PF00413 Peptidase_M10, PF01471 PG_binding_1
- InterPro
- Hemopexin-like_dom, Hemopexin-like_dom_sf, Hemopexin-like_repeat, Hemopexin_CS, M10A_MMP, MetalloPept_cat_dom_sf, Pept_M10_metallopeptidase, Pept_M10A, Pept_M10A_Zn_BS, Peptidase_Metallo, Peptidoglycan-bd-like, PGBD-like_sf
- Functional cluster
- Venom Serine Proteases & Phospholipase A2
Experimental structures · PDB · 44
- 1B3D X-ray 2.30A
- 1B8Y X-ray 2.00A
- 1BIW X-ray 2.50A
- 1BM6 NMR
- 1BQO X-ray 2.30A
- 1C3I X-ray 1.83A
- 1C8T X-ray 2.60A
- 1CAQ X-ray 1.80A
- 1CIZ X-ray 1.64A
- 1CQR X-ray 2.00A
- 1D5J X-ray 2.60A
- 1D7X X-ray 2.00A
- … and 32 more
A predicted model is available from AlphaFold.
Gene Ontology · 27
- GO:0005829 cytosol
- GO:0031012 extracellular matrix
- GO:0005576 extracellular region
- GO:0005615 extracellular space
- GO:0005739 mitochondrion
- GO:0005634 nucleus
- GO:0004175 endopeptidase activity
- GO:0004222 metalloendopeptidase activity
- GO:0008237 metallopeptidase activity
- GO:0008233 peptidase activity
- GO:0004252 serine-type endopeptidase activity
- GO:0008270 zinc ion binding
- GO:0071222 cellular response to lipopolysaccharide
- GO:0071732 cellular response to nitric oxide
- GO:0034614 cellular response to reactive oxygen species
- GO:0071492 cellular response to UV-A
- GO:0030574 collagen catabolic process
- GO:0022617 extracellular matrix disassembly
- GO:0030198 extracellular matrix organization
- GO:0045087 innate immune response
- GO:0051898 negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- GO:2000378 negative regulation of reactive oxygen species metabolic process
- GO:0031334 positive regulation of protein-containing complex assembly
- GO:0030163 protein catabolic process
- GO:0006508 proteolysis
- GO:0150077 regulation of neuroinflammatory response
- GO:1904645 response to amyloid-beta
Disease associations
- coronary heart disease, susceptibility to, 6 MONDO:0013765
Drugs targeting this protein · 2
- MARIMASTAT inhibitor
- CTS-1027 inhibitor
Related proteins · sequence + function similarity
- Stromelysin-1 0.99
- Stromelysin-1 0.98
- Stromelysin-2 0.97
- Stromelysin-2 0.97
- Stromelysin-1 0.96
- Stromelysin-1 0.95
- Stromelysin-2 0.95
- Stromelysin-1 0.95
- Collagenase 3 0.94
- Collagenase 3 0.93
- Interstitial collagenase 0.93
- Collagenase 3 0.93
Co-cited proteins · studied together in the literature
- Stromelysin-1 1 shared papers
- Stromelysin-1 1 shared papers
- Metalloproteinase inhibitor 1 1 shared papers
- Interstitial collagenase 1 shared papers
- Matrix metalloproteinase-9 1 shared papers
Literature · 23 cited papers
- Matrix metalloproteinase 3 restricts viral infection by enhancing host antiviral immunity. Antiviral Res. · 2022
- Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease. Neurochem. Int. · 2012
- Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J. Biol. Chem. · 2011
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. · 2004
- Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. · 2004
- Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. · 2002
- Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator. Eur. J. Biochem. · 2000
- Crystal structure of the stromelysin catalytic domain at 2.0-A resolution: inhibitor-induced conformational changes. J. Mol. Biol. · 1999
- X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity. Protein Sci. · 1999
- Solution structures of stromelysin complexed to thiadiazole inhibitors. Protein Sci. · 1998
- Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity. Protein Sci. · 1998
- Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor. Biochemistry · 1998
- … and 11 more in the literature graph